RDHL Q2 2022 Earnings Deep Losses and Share Price Surge Amid No Revenue GSHD Q1 2026 Earnings EPS Smashes Estimates by 794 Amid Strong Operational Execution Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech PFIS Q1 2026 Earnings Earnings Miss Estimates as EPS Falls Short HEI Q4 2025 Earnings EPS Beats Estimates Amid Mixed Market Signal RNGR Q1 2026 Earnings EPS Misses Estimates by Nearly 39 Amid Operational Headwinds